BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 7877863)

  • 1. [Curative treatment of invasive aspergillosis].
    Dupont B
    Pathol Biol (Paris); 1994 Sep; 42(7):688-93. PubMed ID: 7877863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Curative antifungal treatment of invasive pulmonary aspergillosis].
    Andrès E; Courouau F; Kurtz JE; Limacher JM; Quoix E
    Rev Pneumol Clin; 1995; 51(4):228-31. PubMed ID: 7501940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fungal infections in patients undergoing bone marrow transplantation: an approach to a rational management protocol.
    Castagnola E; Bucci B; Montinaro E; Viscoli C
    Bone Marrow Transplant; 1996 Nov; 18 Suppl 2():97-106. PubMed ID: 8932808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Itraconazole added to a lipid formulation of amphotericin B does not improve outcome of primary treatment of invasive aspergillosis.
    Kontoyiannis DP; Boktour M; Hanna H; Torres HA; Hachem R; Raad II
    Cancer; 2005 Jun; 103(11):2334-7. PubMed ID: 15844093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Aspergillosis in pulmonary transplantation].
    de Pablo A; Ussetti P; Cruz Carreño M; Lázaro T; Ferreiro MJ; López A; Mendaza P; Estada J
    Enferm Infecc Microbiol Clin; 2000 May; 18(5):209-14. PubMed ID: 10974763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drug perspectives in the treatment of invasive aspergillosis].
    Yeni P
    Pathol Biol (Paris); 1994 Sep; 42(7):700-5. PubMed ID: 7877865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Choice and use of antifungal drugs].
    Dupont B
    Rev Prat; 2001 Apr; 51(7):752-7. PubMed ID: 11387672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of chemoprophylaxis in the prevention of invasive aspergillosis].
    Joly V
    Pathol Biol (Paris); 1994 Sep; 42(7):694-9. PubMed ID: 7877864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caspofungin: new preparation. A last resort in invasive aspergillosis.
    Prescrire Int; 2002 Oct; 11(61):142-3. PubMed ID: 12378745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination and sequential antifungal therapy for invasive aspergillosis: review of published in vitro and in vivo interactions and 6281 clinical cases from 1966 to 2001.
    Steinbach WJ; Stevens DA; Denning DW
    Clin Infect Dis; 2003 Oct; 37 Suppl 3():S188-224. PubMed ID: 12975752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poor efficacy of amphotericin B-based therapy in CNS aspergillosis.
    Schwartz S; Ruhnke M; Ribaud P; Reed E; Troke P; Thiel E
    Mycoses; 2007 May; 50(3):196-200. PubMed ID: 17472616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive disseminated aspergillosis in a bone marrow transplant recipient: response with a high-dose lipid formulation of amphotericin B.
    Kontoyiannis DP; Andersson BS; Lewis RE; Raad II
    Clin Infect Dis; 2001 Mar; 32(5):E94-6. PubMed ID: 11229866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Invasive bronchopulmonary aspergillosis treated with itraconazole in a patient with acute leukemia].
    Sarcía-Ruiz JC; Alvarez C; Floristán F; Hernández I; Hernández J; Alvarez Blanco A; Ponton J
    Sangre (Barc); 1993 Oct; 38(5):399-402. PubMed ID: 8140504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America.
    Stevens DA; Kan VL; Judson MA; Morrison VA; Dummer S; Denning DW; Bennett JE; Walsh TJ; Patterson TF; Pankey GA
    Clin Infect Dis; 2000 Apr; 30(4):696-709. PubMed ID: 10770732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant itraconazole in the treatment of destructive sphenoid aspergillosis.
    Rowe-Jones JM; Freedman AR
    Rhinology; 1994 Dec; 32(4):203-7. PubMed ID: 7701229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcome.
    Patterson TF; Boucher HW; Herbrecht R; Denning DW; Lortholary O; Ribaud P; Rubin RH; Wingard JR; DePauw B; Schlamm HT; Troke P; Bennett JE; ;
    Clin Infect Dis; 2005 Nov; 41(10):1448-52. PubMed ID: 16231256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment failure in invasive aspergillosis: susceptibility of deep tissue isolates following treatment with amphotericin B.
    Paterson PJ; Seaton S; Prentice HG; Kibbler CC
    J Antimicrob Chemother; 2003 Nov; 52(5):873-6. PubMed ID: 14519673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probable disseminated cerebral aspergillosis: recovery with medical treatment.
    Avet-Loiseau H; Mechinaud-Lacroix F; Cohen JY; Harousseau JL
    Nouv Rev Fr Hematol (1978); 1994 Dec; 36(6):419-22. PubMed ID: 7753612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chemotherapy of aspergillus lung disease].
    Scholer HJ
    Mykosen; 1983 Apr; 26(4):173-96. PubMed ID: 6306462
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of invasive fungal sinusitis with liposomal amphotericin B: a report of four cases.
    Sungkanuparph S; Sathapatayavongs B; Kunachak S; Luxameechanporn T; Cheewaruangroj W
    J Med Assoc Thai; 2001 Apr; 84(4):593-601. PubMed ID: 11460976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.